Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
A novel series of triazoloquinazolinone derivatives were designed, synthesised, and evaluated for their in vitro biological activities against the SHP2 protein. Moreover, some compounds were evaluated against A375 cells. The results revealed that target compounds possessed moderate to excellent inhi...
Saved in:
Main Authors: | Rongshuang Luo (Author), Zhongyuan Wang (Author), Dali Luo (Author), Yumei Qin (Author), Chunshen Zhao (Author), Di Yang (Author), Tian Lu (Author), Zhixu Zhou (Author), Zhuyan Huang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase
by: Wenjun Ye, et al.
Published: (2022) -
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
by: Yi Le, et al.
Published: (2020) -
Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3Kα inhibitors
by: Rui Chen, et al.
Published: (2023) -
Strategies to overcome drug resistance using SHP2 inhibitors
by: Meng Liu, et al.
Published: (2021) -
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
by: Zhendong Song, et al.
Published: (2021)